An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
It is a hallucinogenic drug, and is a controlled substance designed for use as an aesthetics. It also has now been touted for ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...